Request Demo
Last update 08 May 2026
Risen (Suzhou) Pharma Technology Co., Ltd.
Last update 08 May 2026
Overview
Tags
Neoplasms
Skin and Musculoskeletal Diseases
Immune System Diseases
Small molecule drug
Proteolysis-targeting chimeras (PROTAC)
siRNA
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20253225
评估试验药物1MW5011（原代号RP901）片多次给药在膝骨关节炎患者的安全性、耐受性、药代动力学、药效动力学特征的多中心、随机、阳性药及安慰剂平行对照Ib期临床研究
[Translation] A multicenter, randomized, active-drug and placebo-controlled phase Ib clinical trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of repeated doses of the investigational drug 1MW5011 (formerly RP901) tablets in patients with knee osteoarthritis.
NCT07207070
A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.
CTR20240894
评价RP901片治疗膝骨关节炎的安全性和有效性的多中心、随机、双盲、安慰剂对照II期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the safety and efficacy of RP901 tablets in the treatment of knee osteoarthritis
100 Clinical Results associated with Risen (Suzhou) Pharma Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Risen (Suzhou) Pharma Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Risen (Suzhou) Pharma Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 13 May 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
7
2
Preclinical
IND Application
1
1
IND Approval
Phase 2
1
2
Phase 3
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free